Septerna (NASDAQ:SEPN) Shares Gap Up – Time to Buy?

Septerna, Inc. (NASDAQ:SEPN) shares gapped up prior to trading on Monday . The stock had previously closed at $18.48, but opened at $19.02. Septerna shares last traded at $17.73, with a volume of 12,754 shares traded.

Analyst Ratings Changes

SEPN has been the subject of a number of analyst reports. Wells Fargo & Company began coverage on Septerna in a research note on Tuesday, November 19th. They set an “overweight” rating and a $43.00 price objective for the company. JPMorgan Chase & Co. began coverage on shares of Septerna in a report on Tuesday, November 19th. They issued an “overweight” rating and a $38.00 price target on the stock. Cantor Fitzgerald initiated coverage on shares of Septerna in a research note on Tuesday, November 19th. They set an “overweight” rating and a $50.00 price objective for the company. Finally, TD Cowen began coverage on Septerna in a research note on Tuesday, November 19th. They issued a “buy” rating for the company.

Septerna Trading Down 9.8 %

The company has a fifty day simple moving average of $22.33.

Institutional Trading of Septerna

An institutional investor recently bought a new position in Septerna stock. SG Americas Securities LLC purchased a new position in Septerna, Inc. (NASDAQ:SEPN) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 8,095 shares of the company’s stock, valued at approximately $185,000.

About Septerna

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.